![](/img/cover-not-exists.png)
Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents âPostâhoc Analyses from DECLAREâTIMI 58
Cahn, Avivit, Wiviott, Stephen D., Mosenzon, Ofri, Murphy, Sabina A., Goodrich, Erica L., Yanuv, Ilan, Rozenberg, Aliza, Wilding, John P.H., Leiter, Lawrence A., Bhatt, Deepak L., McGuire, Darren K.,Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.14179
Date:
August, 2020
File:
PDF, 1.39 MB
2020